Disruption of IL-18 signaling via engineered IL-18BP biologics alleviates experimental cholestatic liver disease.
Kim DH, Lee KJ, Park J, Chi S, Han J, Bang Y, Kim SM, Kang SG#, Cha SH#, Han YH#
Biomed Pharmacother, 2023
12
Hepatic TREM2+ macrophages express matrix metalloproteinases to control fibrotic scar formation.
Lee KJ*, An S*, Kim MY, Kim SM, Jeong WI, Ko HJ, Yang YM, Noh M, Han YH
Immunol Cell Biol, 2023
13
Lubiprostone significantly represses fatty liver diseases via induction of mucin and HDL release in mice.
Kim MY*, Lee SJ*, Randolph GJ, Han YH
Life Sci, 2022
14
Chemotactic cytokines secreted from Kupffer cells contribute to the sex-dependent susceptibility to non-alcoholic fatty liver diseases in mice.
Han YH*, Choi H*, Kim HJ, Lee MO
Life Sci, 2022
15
Lipid absorption and overall intestinal lymphatic transport are impaired following partial small bowel resection in mice.
Onufer EJ, Czepielewski RS, Han YH, Courtney CM, Sutton S, Sescleifer A, Randolph GJ, Warner BW
Sci Rep, 2022
16
Roles of heterogenous hepatic macrophages in the progression of liver diseases.
Lee KJ*, Kim MY*, Han YH
BMB Rep, 2022
17
Loss of ERdj5 exacerbates oxidative stress in mice with alcoholic liver disease via suppressing Nrf2.
Hong DG, Song GY, Eom CB, Ahn JH, Kim SM, Shim A, Han YH, Roh YS, Han CY, Bae EJ, Ko HJ, Yang YM
Free Radic Biol Med, 2022
18
RORα contributes to the maintenance of genome ploidy in the liver of mice with diet-induced nonalcoholic steatohepatitis.
Kim JY, Yang IS, Kim HJ, Yoon JY, Han YH, Seong JK, Lee MO
Am J Physiol Endocrinol Metab, 2022
19
Ileitis-associated tertiary lymphoid organs arise at lymphatic valves and impede mesenteric lymph flow in response to tumor necrosis factor.
Czepielewski RS, Erlich EC, Onufer EJ, Young S, Saunders BT, Han YH, Wohltmann M, Wang PL, Kim KW, Kumar S, Hsieh CS, Scallan JP, Yang Y, Zinselmeyer BH, Davis MJ, Randolph GJ
Immunity, 2021
20
RORα Enhances Lysosomal Acidification and Autophagic Flux in the Hepatocytes.